Jennifer Price, MD

Email Jennifer
(415) 502-1429

513 Parnassus Ave, Med Sci
San Francisco, CA 94143

Visit CTSI Profile

  • Assistant Professor, UCSF School of Medicine

Biography

Dr. Jennifer Cohen Price is an Assistant Clinical Professor of Medicine and hepatologist, specializing in treating patients needing liver transplants. Her research interests include liver disease in HIV infection, the natural history and treatment of viral hepatitis, and nonalcoholic fatty liver disease.

Awards

Displaying 1 - 30 of 30

  1. Reid M, Price JC, Tien PC. Hepatitis C Virus Infection in the Older Patient. Infect Dis Clin North Am. 2017 Dec; 31(4):827-838. View on Pubmed
  2. Price JC, Tien PC. Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression? Am J Gastroenterol. 2017 Oct; 112(10):1506-1507. View on Pubmed
  3. Price JC, Dodge JL, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters MG, Noworolski S, Tien PC. Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults. AIDS. 2017 Sep 24; 31(15):2119-2125. View on Pubmed
  4. Price JC, Wang R, Seaberg EC, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Thio CL. The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus. Open Forum Infect Dis. 2017; 4(3):ofx153. View on Pubmed
  5. Price JC, Tien PC. Reply. Hepatology. 2017 Aug; 66(2):674-675. View on Pubmed
  6. Price JC, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters MG, Noworolski SM, Tien PC. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection. Hepatology. 2017 Mar; 65(3):853-863. View on Pubmed
  7. Kardashian A, Ma Y, Scherzer R, Price JC, Sarkar M, Korn N, Tillinghast K, Peters MG, Noworolski SM, Tien PC. Sex differences in the association of HIV infection with hepatic steatosis. AIDS. 2017 Jan 28; 31(3):365-373. View on Pubmed
  8. Reid M, Ma Y, Scherzer R, Price JC, French AL, Plankey MW, Grunfeld C, Tien PC. Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults. AIDS. 2017 Jan 28; 31(3):385-393. View on Pubmed
  9. Park L, Mone A, Price JC, Tzimas D, Hirsh J, Poles MA, Malter L, Chen LA. Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance. Ann Gastroenterol. 2017; 30(1):83-88. View on Pubmed
  10. Konerman MA, Price JC, Campbell CY, Eluri S, Gurakar A, Hamilton J, Li Z. Pre-Liver Transplant Transthoracic Echocardiogram Findings and 6-Month Post-Transplant Outcomes: A Case-Control Analysis. Ann Transplant. 2016 Jul 05; 21:416-27. View on Pubmed
  11. Price JC, Seaberg EC, Phair JP, Witt MD, Koletar SL, Thio CL. Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection. J Acquir Immune Defic Syndr. 2016 Jul 01; 72(3):319-23. View on Pubmed
  12. Kardashian AA, Price JC. Hepatitis C virus-HIV-coinfected patients and liver transplantation. Curr Opin Organ Transplant. 2015 Jun; 20(3):276-85. View on Pubmed
  13. Price JC, Terrault NA. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in. Liver Transpl. 2015 Apr; 21(4):423-34. View on Pubmed
  14. Price JC, Terrault NA. Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective. Liver Int. 2015 Jan; 35(1):7-8. View on Pubmed
  15. Konerman MA, Price J, Torres D, Li Z. Randomized, controlled pilot study comparing large-volume paracentesis using wall suction and traditional glass vacuum bottle methods. Therap Adv Gastroenterol. 2014 Sep; 7(5):184-92. View on Pubmed
  16. Price JC, Murphy RC, Shvachko VA, Pauly MP, Manos MM. Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting. Dig Dis Sci. 2014 Dec; 59(12):3043-52. View on Pubmed
  17. Chen T, Hubbard A, Murtazina R, Price J, Yang J, Cha B, Sarker R, Donowitz M. Myosin VI mediates the movement of NHE3 down the microvillus in intestinal epithelial cells. J Cell Sci. 2014 Aug 15; 127(Pt 16):3535-45. View on Pubmed
  18. Price JC, Seaberg EC, Latanich R, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Thio CL. Risk factors for fatty liver in the Multicenter AIDS Cohort Study. Am J Gastroenterol. 2014 May; 109(5):695-704. View on Pubmed
  19. Jodorkovsky D, Price JC, Kim B, Dhalla S, Stein EM, Clarke JO. Multichannel intraluminal impedance-pH testing is clinically useful in the management of patients with gastroesophageal reflux symptoms. Dig Dis Sci. 2014 Aug; 59(8):1817-22. View on Pubmed
  20. Price J. An update on hepatitis B, D, and E viruses. Top Antivir Med. 2014 Jan; 21(5):157-63. View on Pubmed
  21. Gulsen MT, Girotra M, Cengiz-Seval G, Price J, Singh VK, Segev DL, Cameron AM, Gurakar A. HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience. Ann Transplant. 2013 Feb 20; 18:69-75. View on Pubmed
  22. Price JC. Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation. Current Hepatitis Reports. 2013; 12(4):227-235.
  23. Price J, Thio C. Reply to Post and Sabin. J Infect Dis. 2013 Jan 15; 207(2):368-9.
  24. Price JC, Seaberg EC, Badri S, Witt MD, D'Acunto K, Thio CL. HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis. 2012 Mar 15; 205(6):1005-13.
  25. Price JC, Thio CL. Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol. 2010 Dec; 8(12):1002-12.
  26. Liang DB, Price JC, Ahmed H, Farmer N, Montgomery EA, Giday SA. Gastric sarcoidosis: case report and literature review. J Natl Med Assoc. 2010 Apr; 102(4):348-51.
  27. Price J and Li Z. . Hepatitis B- Recent Developments in Therapy. European Gastroenterology & Hepatology Review. 2009; 5(1):38-42.
  28. O'Toole TP, Conde-Martel A, Young JH, Price J, Bigelow G, Ford DE. Managing acutely ill substance-abusing patients in an integrated day hospital outpatient program: medical therapies, complications, and overall treatment outcomes. J Gen Intern Med. 2006 Jun; 21(6):570-6.
  29. Miller RG, Ashar BH, Cohen J, Camp M, Coombs C, Johnson E, Schneyer CR. Disparities in osteoporosis screening between at-risk African-American and white women. J Gen Intern Med. 2005 Sep; 20(9):847-51.
  30. Cohen JG, Dryja TP, Davis KB, Diller LR, Li FP. RB1 genetic testing as a clinical service: a follow-up study. Med Pediatr Oncol. 2001 Oct; 37(4):372-8.